![PDF) Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART) PDF) Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)](https://i1.rgstatic.net/publication/289500427_Randomized_active-controlled_comparative_phase_3_efficacy_and_safety_equivalence_trial_of_OvaleapR_recombinant_human_follicle-stimulating_hormone_in_infertile_women_using_assisted_reproduction_technol/links/5fc4c40892851c933f77aea0/largepreview.png)
PDF) Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)
![Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study | Reproductive ... Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study | Reproductive ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12958-020-00610-2/MediaObjects/12958_2020_610_Fig1_HTML.png)
Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study | Reproductive ...
![Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study - ScienceDirect Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405661818300029-t1.jpg)